Cheek Augmentation
7
1
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
80%
4 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Evaluation of Performance and Safety of Injectable KIO017 Device Range for Facial Tissue Filling
Evaluation of Facial HA Dermal Fillers in Real-Life Conditions
RHA®4 for Midface Volume Deficiency
Preliminary Safety and Effectiveness of SMI-01 as a Tissue Filler
Study to Evaluate Satisfaction After Treatment With Restylane
Injection Technique Assessment of Restylane Lyft With Lidocaine for Cheek Augmentation
GAL1704 for Cheek Augmentation and Correction of Midface Contour Deficiencies